Deferiprone is a medication used to treat iron overload in the body, particularly in patients with thalassemia. However, the drug may contain impurities that can affect its potency and safety. Deferiprone impurities may include degradation products, isomers, and other chemical substances that can impact the drug's efficacy and cause adverse effects. It is essential to identify and control these impurities to ensure the drug's quality and safety for patients.
